
Norgine has announced its exclusive licensing agreement with Vir Biotechnology, under which Norgine will commercialise the combination of tobevibart and …

Vir Biotechnology and GSK have announced that their monoclonal-antibody drug has been found to reduce hospitalisations or deaths from COVID-19 …

Vir Biotechnology, a developer of treatments that induce protective and therapeutics immune responses, has hired a CSO with a strong …

All has been quiet since former Biogen CEO, George Scangos, departed the company and then set up Vir Biotechnology in …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

